-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Anavex Life Sciences, Maintains $20 Price Target

Benzinga·02/10/2026 12:44:01
Listen to the news
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $20 price target.